
ECO ANIMAL HEALTH GROUP PLC — Investor Relations & Filings
ECO Animal Health Group is a global company specializing in the development, registration, and marketing of pharmaceutical and biological products for animal health. The company's primary focus is on improving the health, welfare, and productivity of pigs and poultry by addressing economically significant respiratory and enteric diseases. Its key product is Aivlosin®, a macrolide antibiotic also marketed as Valosin®. Through its dedicated research and development, the company creates innovative solutions, including vaccines and other pharmaceuticals, to support sustainable and safe food production. ECO Animal Health operates worldwide, leveraging a global network of distributors and direct market presence.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Renewal of revolving credit facility | 2026-06-04 | English | |
| Appointment of Head of Business Development | 2026-04-14 | English | |
| Board Change | 2026-03-31 | English | |
| Full Year Trading Update | 2026-03-19 | English | |
| ECOVAXXIN® MG favourable USDA safety assessment | 2026-03-11 | English | |
| Block Listing Return | 2026-03-05 | English |
Browse filings by year
34 years- 2026 8 filings
- 2025 32 filings
- 2024 35 filings
- 2023 25 filings
- 2022 38 filings
- 2021 32 filings
- 2020 25 filings
- 2019 40 filings
- 2018 45 filings
- 2017 30 filings
- 2016 43 filings
- 2015 37 filings
- 2014 9 filings
- 2013 21 filings
- 2012 1 filing
- 2011 1 filing
- 2010 1 filing
- 2009 1 filing
- 2008 1 filing
- 2007 1 filing
- 2006 1 filing
- 2005 1 filing
- 2004 1 filing
- 2003 1 filing
- 2002 1 filing
- 2001 1 filing
- 2000 1 filing
- 1999 1 filing
- 1998 1 filing
- 1997 1 filing
- 1996 1 filing
- 1995 1 filing
- 1992 1 filing
- 1991 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 47961933 | Renewal of revolving credit facility | 2026-06-04 | English | ||
| 34655152 | Appointment of Head of Business Development | 2026-04-14 | English | ||
| 33101902 | Board Change | 2026-03-31 | English | ||
| 32983131 | Full Year Trading Update | 2026-03-19 | English | ||
| 32927389 | ECOVAXXIN® MG favourable USDA safety assessment | 2026-03-11 | English | ||
| 32904406 | Block Listing Return | 2026-03-05 | English | ||
| 34565952 | EU launch plans for ECOVAXXIN® MS | 2026-02-26 | English | ||
| 13024079 | Holding(s) in Company | 2026-01-19 | English | ||
|
2025
7 filings
| |||||
| 10568050 | ECOVAXXIN® MS EU marketing authorisation granted | 2025-12-22 | English | ||
| 10361380 | Exercise of Share Options by Director | 2025-12-18 | English | ||
| 9717968 | Holding(s) in Company | 2025-12-09 | English | ||
| 9286057 | Director/PDMR Shareholding | 2025-12-04 | English | ||
| 8954087 | Results for the six months ended 30 September 2025 | 2025-12-01 | English | ||
| 8480999 | Replacement: Notice of Results | 2025-11-20 | English | ||
| 8479164 | Notice of Results | 2025-11-20 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for ECO ANIMAL HEALTH GROUP PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ECO ANIMAL HEALTH GROUP PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7612/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7612 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7612 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7612 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7612}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ECO ANIMAL HEALTH GROUP PLC (id: 7612)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.